Millions of people in the world suffer ill health because there is no commercial incentive to develop the products they need.
We are here to help fix that.
New report: Doing Well by Doing Good
Our new report, co-authored with the Global Health Technologies Coalition, examines how US federal funding for global health R&D is delivering impact both at home and abroad.
March 2024
See more
New: 2023 Neglected Disease G-FINDER Report
Our latest Neglected Disease G-FINDER report analyses R&D funding in 2022, providing insights into investment trends, funders and the product pipeline.
January 2024
See more
New: 3rd report on the 100 Days Mission for pandemic preparedness
We created the report's scorecard which provides a comprehensive assessment of the pipeline and R&D funding for the WHO R&D Blueprint pathogens of pandemic potential. Our pipeline tracker is here: policycuresresearch.org/pipeline-database and our funding portal is here: gfinderdata.policycuresresearch.org. Click 'See more' for a link to the report and scorecard.
January 2024
See more
New: 2023 Sexual & Reproductive Health G-FINDER Report
Our latest sexual and reproductive health G-FINDER report analyses the latest R&D funding trends for low- and middle-income contexts. We look at investments for STIs, HPV, contraception, multipurpose prevention technologies and maternal health issues.
October 2023
See more
G-FINDER snapshot: Fighting Ebola and Marburg- unfinished business
Our latest G-FINDER snapshot shows how R&D funding responded to Ebola and Marburg outbreaks and analyses the resulting products and pipeline.
July 2023
See more
Project: Evidence for Impact
We seek to establish a framework that the global health community can leverage to assess the health and economic impact of the past 20 years of investment in R&D for neglected diseases and emerging infectious diseases. The resulting insights will aim to inform investment decisions, tradeoffs or required shifts in the product development ecosystem.
December 2022
See more
G-FINDER Data Portal
Our unique database of R&D investment data for global health issues can be freely accessed through the G-FINDER data portal.
See more
Policy Cures Research is a global health research & policy organisation. Our mission is to improve the health of the world’s most disadvantaged people and populations by using evidence to drive medical research and biomedical innovation for historically neglected and underfunded health issues.
We provide robust evidence, high-quality analysis, and engage with the global health community to offer strategic advice and expertise to stimulate efficient funding for biomedical research and development.
Our aim is to provide governments, funders and civil society organisations with the information they need to make optimal R&D policy and funding decisions to improve the health outcomes of those who are most underserved.
Our vision is a world where researchers and funders work collaboratively to drive biomedical innovation – irrespective of commercial incentives – so that all people, regardless of where they live, have the medical products, tools and technologies they need to combat disease and promote good health.
Evidence
We gather evidence by collecting two types of data: funding for global health R&D and information on biomedical products in the R&D pipeline. Funding data is gathered on an annual basis via the G-FINDER survey while our R&D pipeline tracker is updated at regular intervals throughout the year.
Analysis
We use evidence collected through the G-FINDER survey and our R&D pipeline tracker to produce reports on a range of issues in global health.
Engagement
We share our knowledge and expertise to ensure policy-makers, researchers and industry have the data they need to make informed decisions when they invest in global health R&D.
